Global HER-2 Negative Breast Cancer Market Growth (Status and Outlook) 2023-2029

March 2023 | 88 pages | ID: G225028767ECEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “HER-2 Negative Breast Cancer Industry Forecast” looks at past sales and reviews total world HER-2 Negative Breast Cancer sales in 2022, providing a comprehensive analysis by region and market sector of projected HER-2 Negative Breast Cancer sales for 2023 through 2029. With HER-2 Negative Breast Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HER-2 Negative Breast Cancer industry.

This Insight Report provides a comprehensive analysis of the global HER-2 Negative Breast Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HER-2 Negative Breast Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HER-2 Negative Breast Cancer market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HER-2 Negative Breast Cancer and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HER-2 Negative Breast Cancer.

The global HER-2 Negative Breast Cancer market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for HER-2 Negative Breast Cancer is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for HER-2 Negative Breast Cancer is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for HER-2 Negative Breast Cancer is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key HER-2 Negative Breast Cancer players cover Eli Lilly and Company, AstraZeneca, GSK, Novartis AG and Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of HER-2 Negative Breast Cancer market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Chemotherapy
• Radiation
• Hormonal Therapy
• Others

Segmentation by application

• Hospital
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Eli Lilly and Company
• AstraZeneca
• GSK
• Novartis AG
• Pfizer

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global HER-2 Negative Breast Cancer Market Size 2018-2029
  2.1.2 HER-2 Negative Breast Cancer Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 HER-2 Negative Breast Cancer Segment by Type
  2.2.1 Chemotherapy
  2.2.2 Radiation
  2.2.3 Hormonal Therapy
  2.2.4 Others
2.3 HER-2 Negative Breast Cancer Market Size by Type
  2.3.1 HER-2 Negative Breast Cancer Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global HER-2 Negative Breast Cancer Market Size Market Share by Type (2018-2023)
2.4 HER-2 Negative Breast Cancer Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Other
2.5 HER-2 Negative Breast Cancer Market Size by Application
  2.5.1 HER-2 Negative Breast Cancer Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global HER-2 Negative Breast Cancer Market Size Market Share by Application (2018-2023)

3 HER-2 NEGATIVE BREAST CANCER MARKET SIZE BY PLAYER

3.1 HER-2 Negative Breast Cancer Market Size Market Share by Players
  3.1.1 Global HER-2 Negative Breast Cancer Revenue by Players (2018-2023)
  3.1.2 Global HER-2 Negative Breast Cancer Revenue Market Share by Players (2018-2023)
3.2 Global HER-2 Negative Breast Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HER-2 NEGATIVE BREAST CANCER BY REGIONS

4.1 HER-2 Negative Breast Cancer Market Size by Regions (2018-2023)
4.2 Americas HER-2 Negative Breast Cancer Market Size Growth (2018-2023)
4.3 APAC HER-2 Negative Breast Cancer Market Size Growth (2018-2023)
4.4 Europe HER-2 Negative Breast Cancer Market Size Growth (2018-2023)
4.5 Middle East & Africa HER-2 Negative Breast Cancer Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas HER-2 Negative Breast Cancer Market Size by Country (2018-2023)
5.2 Americas HER-2 Negative Breast Cancer Market Size by Type (2018-2023)
5.3 Americas HER-2 Negative Breast Cancer Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC HER-2 Negative Breast Cancer Market Size by Region (2018-2023)
6.2 APAC HER-2 Negative Breast Cancer Market Size by Type (2018-2023)
6.3 APAC HER-2 Negative Breast Cancer Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe HER-2 Negative Breast Cancer by Country (2018-2023)
7.2 Europe HER-2 Negative Breast Cancer Market Size by Type (2018-2023)
7.3 Europe HER-2 Negative Breast Cancer Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa HER-2 Negative Breast Cancer by Region (2018-2023)
8.2 Middle East & Africa HER-2 Negative Breast Cancer Market Size by Type (2018-2023)
8.3 Middle East & Africa HER-2 Negative Breast Cancer Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HER-2 NEGATIVE BREAST CANCER MARKET FORECAST

10.1 Global HER-2 Negative Breast Cancer Forecast by Regions (2024-2029)
  10.1.1 Global HER-2 Negative Breast Cancer Forecast by Regions (2024-2029)
  10.1.2 Americas HER-2 Negative Breast Cancer Forecast
  10.1.3 APAC HER-2 Negative Breast Cancer Forecast
  10.1.4 Europe HER-2 Negative Breast Cancer Forecast
  10.1.5 Middle East & Africa HER-2 Negative Breast Cancer Forecast
10.2 Americas HER-2 Negative Breast Cancer Forecast by Country (2024-2029)
  10.2.1 United States HER-2 Negative Breast Cancer Market Forecast
  10.2.2 Canada HER-2 Negative Breast Cancer Market Forecast
  10.2.3 Mexico HER-2 Negative Breast Cancer Market Forecast
  10.2.4 Brazil HER-2 Negative Breast Cancer Market Forecast
10.3 APAC HER-2 Negative Breast Cancer Forecast by Region (2024-2029)
  10.3.1 China HER-2 Negative Breast Cancer Market Forecast
  10.3.2 Japan HER-2 Negative Breast Cancer Market Forecast
  10.3.3 Korea HER-2 Negative Breast Cancer Market Forecast
  10.3.4 Southeast Asia HER-2 Negative Breast Cancer Market Forecast
  10.3.5 India HER-2 Negative Breast Cancer Market Forecast
  10.3.6 Australia HER-2 Negative Breast Cancer Market Forecast
10.4 Europe HER-2 Negative Breast Cancer Forecast by Country (2024-2029)
  10.4.1 Germany HER-2 Negative Breast Cancer Market Forecast
  10.4.2 France HER-2 Negative Breast Cancer Market Forecast
  10.4.3 UK HER-2 Negative Breast Cancer Market Forecast
  10.4.4 Italy HER-2 Negative Breast Cancer Market Forecast
  10.4.5 Russia HER-2 Negative Breast Cancer Market Forecast
10.5 Middle East & Africa HER-2 Negative Breast Cancer Forecast by Region (2024-2029)
  10.5.1 Egypt HER-2 Negative Breast Cancer Market Forecast
  10.5.2 South Africa HER-2 Negative Breast Cancer Market Forecast
  10.5.3 Israel HER-2 Negative Breast Cancer Market Forecast
  10.5.4 Turkey HER-2 Negative Breast Cancer Market Forecast
  10.5.5 GCC Countries HER-2 Negative Breast Cancer Market Forecast
10.6 Global HER-2 Negative Breast Cancer Forecast by Type (2024-2029)
10.7 Global HER-2 Negative Breast Cancer Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Eli Lilly and Company
  11.1.1 Eli Lilly and Company Company Information
  11.1.2 Eli Lilly and Company HER-2 Negative Breast Cancer Product Offered
  11.1.3 Eli Lilly and Company HER-2 Negative Breast Cancer Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Eli Lilly and Company Main Business Overview
  11.1.5 Eli Lilly and Company Latest Developments
11.2 AstraZeneca
  11.2.1 AstraZeneca Company Information
  11.2.2 AstraZeneca HER-2 Negative Breast Cancer Product Offered
  11.2.3 AstraZeneca HER-2 Negative Breast Cancer Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 AstraZeneca Main Business Overview
  11.2.5 AstraZeneca Latest Developments
11.3 GSK
  11.3.1 GSK Company Information
  11.3.2 GSK HER-2 Negative Breast Cancer Product Offered
  11.3.3 GSK HER-2 Negative Breast Cancer Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 GSK Main Business Overview
  11.3.5 GSK Latest Developments
11.4 Novartis AG
  11.4.1 Novartis AG Company Information
  11.4.2 Novartis AG HER-2 Negative Breast Cancer Product Offered
  11.4.3 Novartis AG HER-2 Negative Breast Cancer Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Novartis AG Main Business Overview
  11.4.5 Novartis AG Latest Developments
11.5 Pfizer
  11.5.1 Pfizer Company Information
  11.5.2 Pfizer HER-2 Negative Breast Cancer Product Offered
  11.5.3 Pfizer HER-2 Negative Breast Cancer Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Pfizer Main Business Overview
  11.5.5 Pfizer Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. HER-2 Negative Breast Cancer Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Chemotherapy
Table 3. Major Players of Radiation
Table 4. Major Players of Hormonal Therapy
Table 5. Major Players of Others
Table 6. HER-2 Negative Breast Cancer Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global HER-2 Negative Breast Cancer Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global HER-2 Negative Breast Cancer Market Size Market Share by Type (2018-2023)
Table 9. HER-2 Negative Breast Cancer Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global HER-2 Negative Breast Cancer Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global HER-2 Negative Breast Cancer Market Size Market Share by Application (2018-2023)
Table 12. Global HER-2 Negative Breast Cancer Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global HER-2 Negative Breast Cancer Revenue Market Share by Player (2018-2023)
Table 14. HER-2 Negative Breast Cancer Key Players Head office and Products Offered
Table 15. HER-2 Negative Breast Cancer Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global HER-2 Negative Breast Cancer Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global HER-2 Negative Breast Cancer Market Size Market Share by Regions (2018-2023)
Table 20. Global HER-2 Negative Breast Cancer Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global HER-2 Negative Breast Cancer Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas HER-2 Negative Breast Cancer Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas HER-2 Negative Breast Cancer Market Size Market Share by Country (2018-2023)
Table 24. Americas HER-2 Negative Breast Cancer Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas HER-2 Negative Breast Cancer Market Size Market Share by Type (2018-2023)
Table 26. Americas HER-2 Negative Breast Cancer Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas HER-2 Negative Breast Cancer Market Size Market Share by Application (2018-2023)
Table 28. APAC HER-2 Negative Breast Cancer Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC HER-2 Negative Breast Cancer Market Size Market Share by Region (2018-2023)
Table 30. APAC HER-2 Negative Breast Cancer Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC HER-2 Negative Breast Cancer Market Size Market Share by Type (2018-2023)
Table 32. APAC HER-2 Negative Breast Cancer Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC HER-2 Negative Breast Cancer Market Size Market Share by Application (2018-2023)
Table 34. Europe HER-2 Negative Breast Cancer Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe HER-2 Negative Breast Cancer Market Size Market Share by Country (2018-2023)
Table 36. Europe HER-2 Negative Breast Cancer Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe HER-2 Negative Breast Cancer Market Size Market Share by Type (2018-2023)
Table 38. Europe HER-2 Negative Breast Cancer Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe HER-2 Negative Breast Cancer Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa HER-2 Negative Breast Cancer Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa HER-2 Negative Breast Cancer Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa HER-2 Negative Breast Cancer Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa HER-2 Negative Breast Cancer Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa HER-2 Negative Breast Cancer Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa HER-2 Negative Breast Cancer Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of HER-2 Negative Breast Cancer
Table 47. Key Market Challenges & Risks of HER-2 Negative Breast Cancer
Table 48. Key Industry Trends of HER-2 Negative Breast Cancer
Table 49. Global HER-2 Negative Breast Cancer Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global HER-2 Negative Breast Cancer Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global HER-2 Negative Breast Cancer Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global HER-2 Negative Breast Cancer Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Eli Lilly and Company Details, Company Type, HER-2 Negative Breast Cancer Area Served and Its Competitors
Table 54. Eli Lilly and Company HER-2 Negative Breast Cancer Product Offered
Table 55. Eli Lilly and Company HER-2 Negative Breast Cancer Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Eli Lilly and Company Main Business
Table 57. Eli Lilly and Company Latest Developments
Table 58. AstraZeneca Details, Company Type, HER-2 Negative Breast Cancer Area Served and Its Competitors
Table 59. AstraZeneca HER-2 Negative Breast Cancer Product Offered
Table 60. AstraZeneca Main Business
Table 61. AstraZeneca HER-2 Negative Breast Cancer Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. AstraZeneca Latest Developments
Table 63. GSK Details, Company Type, HER-2 Negative Breast Cancer Area Served and Its Competitors
Table 64. GSK HER-2 Negative Breast Cancer Product Offered
Table 65. GSK Main Business
Table 66. GSK HER-2 Negative Breast Cancer Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. GSK Latest Developments
Table 68. Novartis AG Details, Company Type, HER-2 Negative Breast Cancer Area Served and Its Competitors
Table 69. Novartis AG HER-2 Negative Breast Cancer Product Offered
Table 70. Novartis AG Main Business
Table 71. Novartis AG HER-2 Negative Breast Cancer Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Novartis AG Latest Developments
Table 73. Pfizer Details, Company Type, HER-2 Negative Breast Cancer Area Served and Its Competitors
Table 74. Pfizer HER-2 Negative Breast Cancer Product Offered
Table 75. Pfizer Main Business
Table 76. Pfizer HER-2 Negative Breast Cancer Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. HER-2 Negative Breast Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global HER-2 Negative Breast Cancer Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. HER-2 Negative Breast Cancer Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. HER-2 Negative Breast Cancer Sales Market Share by Country/Region (2022)
Figure 8. HER-2 Negative Breast Cancer Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global HER-2 Negative Breast Cancer Market Size Market Share by Type in 2022
Figure 10. HER-2 Negative Breast Cancer in Hospital
Figure 11. Global HER-2 Negative Breast Cancer Market: Hospital (2018-2023) & ($ Millions)
Figure 12. HER-2 Negative Breast Cancer in Clinic
Figure 13. Global HER-2 Negative Breast Cancer Market: Clinic (2018-2023) & ($ Millions)
Figure 14. HER-2 Negative Breast Cancer in Other
Figure 15. Global HER-2 Negative Breast Cancer Market: Other (2018-2023) & ($ Millions)
Figure 16. Global HER-2 Negative Breast Cancer Market Size Market Share by Application in 2022
Figure 17. Global HER-2 Negative Breast Cancer Revenue Market Share by Player in 2022
Figure 18. Global HER-2 Negative Breast Cancer Market Size Market Share by Regions (2018-2023)
Figure 19. Americas HER-2 Negative Breast Cancer Market Size 2018-2023 ($ Millions)
Figure 20. APAC HER-2 Negative Breast Cancer Market Size 2018-2023 ($ Millions)
Figure 21. Europe HER-2 Negative Breast Cancer Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa HER-2 Negative Breast Cancer Market Size 2018-2023 ($ Millions)
Figure 23. Americas HER-2 Negative Breast Cancer Value Market Share by Country in 2022
Figure 24. United States HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC HER-2 Negative Breast Cancer Market Size Market Share by Region in 2022
Figure 29. APAC HER-2 Negative Breast Cancer Market Size Market Share by Type in 2022
Figure 30. APAC HER-2 Negative Breast Cancer Market Size Market Share by Application in 2022
Figure 31. China HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 35. India HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe HER-2 Negative Breast Cancer Market Size Market Share by Country in 2022
Figure 38. Europe HER-2 Negative Breast Cancer Market Size Market Share by Type (2018-2023)
Figure 39. Europe HER-2 Negative Breast Cancer Market Size Market Share by Application (2018-2023)
Figure 40. Germany HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 41. France HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa HER-2 Negative Breast Cancer Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa HER-2 Negative Breast Cancer Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa HER-2 Negative Breast Cancer Market Size Market Share by Application (2018-2023)
Figure 48. Egypt HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country HER-2 Negative Breast Cancer Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 54. APAC HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 55. Europe HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 57. United States HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 58. Canada HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 59. Mexico HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 60. Brazil HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 61. China HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 62. Japan HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 63. Korea HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 65. India HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 66. Australia HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 67. Germany HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 68. France HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 69. UK HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 70. Italy HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 71. Russia HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 72. Spain HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 73. Egypt HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 74. South Africa HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 75. Israel HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 76. Turkey HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries HER-2 Negative Breast Cancer Market Size 2024-2029 ($ Millions)
Figure 78. Global HER-2 Negative Breast Cancer Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global HER-2 Negative Breast Cancer Market Size Market Share Forecast by Application (2024-2029)